Incyte to Report Fourth Quarter and Year-End 2022 Financial Results
January 17 2023 - 8:00AM
Business Wire
Incyte (Nasdaq:INCY) announced today that it has scheduled its
fourth quarter and year-end 2022 financial results conference call
and webcast for 8:00 a.m. ET on Tuesday, February 7, 2023.
The schedule for the press release and conference call/webcast
is as follows:
- Q4 & YE 2022 Press Release: February 7, 2023 at 7:00 a.m.
ET
- Q4 & YE 2022 Conference Call: February 7, 2023 at 8:00 a.m.
ET
- Domestic Dial-In Number: 877-407-3042
- International Dial-In Number: 201-389-0864
- Conference ID Number: 13735569
If you are unable to participate, a replay of the conference
call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for
international callers is 201-612-7415. To access the replay
you will need the conference ID number 13735569.
The live webcast with slides can be accessed at
Investor.Incyte.com and will be available for replay for 90
days.
About Incyte Incyte is a Wilmington,
Delaware-based, global biopharmaceutical company focused on finding
solutions for serious unmet medical needs through the discovery,
development and commercialization of proprietary therapeutics. For
additional information on Incyte, please visit Incyte.com and
follow @Incyte.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230117005125/en/
Incyte Contacts Media
Catalina Loveman +1 302 498 6171 cloveman@incyte.com
Investors Christine Chiou +1 302 274 4773
cchiou@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2023 to Jul 2024